Do radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma?
Tumor growth kinetics can identify contrast-enhancing diffuse astrocytomas undergoing malignant transformation.
Our findings suggested that MUC1 plays an important role in CCL21-CCR7-induced lymphatic metastasis and may serve as a therapeutic target in ESCC.